UP Board Class 12 Question Papers 2026 are available here for students appearing in the ongoing board examinations. The UP ...

Sign up for Chalkbeat New York’s free daily newsletter to get essential news about NYC’s public schools delivered to your inbox. Mayor Zohran Mamdani’s ...

When Keying Liu joined the Master of Medical Sciences in Immunology program at Harvard Medical School, she was drawn by a deep interest in immunology and by the opportunity to spend time thinking ...

Lawmakers reintroduced the Rebuild America’s Schools Act, proposing $130 billion for K-12 facility upgrades. $100 billion would flow through state formula grants, with 95% passed through to districts ...

When the Conner and Scott football teams meet in a Class 5A district game next season, there will be a new head coach on both sidelines. Conner has filled its head coaching vacancy with Chase Floyd, ...

President Donald Trump's administration announced plans to begin stockpiling critical minerals on Monday, starting off the program with $12 billion in seed money, Fox News has learned. The new program ...

Plaintiff class action lawyers believe that they have found a new type of employee benefit program to go after for potential fiduciary breach violations – voluntary benefits. On December 23, 2025, ...

Chef Im Sung Geun—who appeared on Netflix’s “Culinary Class Wars 2”—has revealed that he was convicted three times for drunk driving in the past. On January 18, Im Sung Geun confessed via his YouTube ...

QUESTION: How can I tell what’s causing my Windows computer to bog down? ANSWER: When a computer starts crawling, most people assume it’s old, broken, or infected. In reality, it’s often just ...

When making a Dungeons and Dragons character, few decisions are as important as the class. Furthermore, players must consider what level the campaign is reaching, as any given class is going to ...

HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules for patients with cancer and ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases ...